Cefobid and Blushing - a phase IV clinical study of FDA data
Summary:
Blushing is reported as a side effect among people who take Cefobid (cefoperazone sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Amikacin Sulfate, and have Infection.
The phase IV clinical study analyzes which people have Blushing when taking Cefobid. It is created by eHealthMe based on reports of 1,316 people who have side effects when taking Cefobid from the FDA, and is updated regularly.
What is Cefobid?
Cefobid has active ingredients of cefoperazone sodium. eHealthMe is studying from 1,317 Cefobid users. Check the latest studies of Cefobid.
What is Blushing?
Blushing is found to be associated with 3,153 drugs and 2,919 conditions by eHealthMe. Check the latest studies of Blushing.
1,316 people reported to have side effects when taking Cefobid.
Among them, 14 people (1.06%) have Blushing.

Among these 14 people:
How long have people been on Cefobid when they have Blushing? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Blushing when taking Cefobid? *
- female: 41.67 %
- male: 58.33 %
What is the age of people who have Blushing when taking Cefobid? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 14.29 %
- 20-29: 21.43 %
- 30-39: 14.29 %
- 40-49: 0.0 %
- 50-59: 7.14 %
- 60+: 42.86 %
What are other drugs people take besides Cefobid? *
- Pravachol: 1 person, 7.14%
- Nitroglycerin: 1 person, 7.14%
- Dilacor Xr: 1 person, 7.14%
- Cephalexin: 1 person, 7.14%
- Artesunate: 1 person, 7.14%
- Amikacin Sulfate: 1 person, 7.14%
What are other side effects people have besides Blushing? *
- Acute Circulatory Failure (shock): 7 people, 50.00%
- Hypotension (abnormally low blood pressure): 5 people, 35.71%
- Depressed Level Of Consciousness: 3 people, 21.43%
- Pulse Absent: 2 people, 14.29%
- Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 2 people, 14.29%
- Itching: 2 people, 14.29%
- Paleness (unusual lightness of skin colour): 1 person, 7.14%
- Fever: 1 person, 7.14%
- Taste Disturbance: 1 person, 7.14%
- Back Pain: 1 person, 7.14%
What are the existing conditions these people have? *
- Pneumonia: 1 person, 7.14%
- Infection: 1 person, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Cefobid and have Blushing?
- Check whether Blushing is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Cefobid:
- Cefobid (1,317 reports)
Blushing treatments and more:
- Blushing (117,676 reports)
How severe was Blushing and when was it recovered:
Expand to all the drugs that have ingredients of cefoperazone sodium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cefobid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Blushing:
- Blushing (3,153 drugs)
Browse all the conditions that are associated with Blushing:
- Blushing (2,919 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on cefoperazone sodium (the active ingredients of Cefobid) and Cefobid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Levetiracetam and Acetaminophen - 18 seconds ago
- Drug interactions of Cardizem and Tasmar - 19 seconds ago
- Could Ticlid cause Lymphopenia? - 26 seconds ago
- Drug interactions of Onglyza and Levoxyl - 26 seconds ago
- Could Asa cause Thrombocytopenia Aggravated? - 36 seconds ago
- Drug interactions of Onglyza and Norvir - 40 seconds ago
- Could Omeprazole Magnesium cause Peptic Ulcer Aggravated? - 43 seconds ago
- Could Tamsulosin Hydrochloride cause Major Depression? - 43 seconds ago
- Drug interactions of Calcium Acetate and Fenofibrate - 45 seconds ago
- Drug interactions of Aimovig and Mounjaro - 46 seconds ago